Positron Emission Tomography (PET) Scanners Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The positron emission tomography (PET) scanners market size has grown strongly in recent years. It will grow from $1.51 billion in 2024 to $1.6 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to advancements in radiopharmaceuticals, increased cancer diagnoses, clinical applications expansion, healthcare infrastructure development, growing emphasis on early disease detection.

The positron emission tomography (PET) scanners market size is expected to see strong growth in the next few years. It will grow to $1.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to rising incidence of neurological disorders, integration of ai in imaging, oncology research and personalized medicine, expanding applications in cardiology, increasing aging population. Major trends in the forecast period include technological innovations in imaging, advancements in digital detector technology, emergence of total-body pet scanners, expanding applications in neurology, hybrid pet/MRI systems.

The anticipated increase in cases of brain disorders is set to drive the growth of the positron emission tomography (PET) scanners market in the foreseeable future. Brain disorders, resulting from factors such as illness, genetics, or traumatic injury, impact the normal functioning of the brain. PET scans, utilizing a radioactive tracer, reveal both normal and abnormal metabolic activity in the brain. This technology is crucial for monitoring brain function, disease processes, treatment responses, and diagnosing conditions not visible in other imaging methods. For example, the Alzheimer's Association reports that as of 2022, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to reach 13.8 million by 2060. Thus, the escalating number of brain disorder cases is a key driver for the growth of the positron emission tomography (PET) scanners market.

The rising incidence of brain disorders is anticipated to drive the growth of the positron emission tomography (PET) scanners market in the future. A brain disorder refers to any condition that disrupts the normal functioning of the brain, which can be caused by illness, genetics, or traumatic injuries. PET scans utilize a radioactive substance known as a tracer to visualize both normal and abnormal metabolic activities in the brain. They are instrumental in monitoring brain function, disease progression, treatment responses, and diagnosing conditions that may not be visible through other imaging methods. For example, in March 2024, the Alzheimer's Association, a US-based non-profit organization, reported that approximately 6.9 million Americans aged 65 and older are living with Alzheimer's dementia as of 2024. This number is projected to rise to 13.8 million by 2060. Consequently, the increasing prevalence of brain disorders is propelling the growth of the positron emission tomography (PET) scanners market.

Key players in the positron emission tomography (PET) scanner market are focusing on innovation by adopting new technologies such as Optiso Ultra Dynamic Range (UDR) detector technology to enhance their services. The Optiso UDR detector, a next-generation PET detector, employs multiple technologies for optimal performance in various count rates. Siemens Healthineers AG introduced the Biograph Vision X, a PET/CT scanner utilizing Optiso UDR detector technology to improve image quality and diagnostic accuracy. The scanner achieves higher spatial resolution and a 20% performance enhancement through the use of small LSO crystals coated by SiPMs.

In August 2022, Positron Corporation, a US-based company specializing in nuclear medicine PET imaging, acquired its first PET-CT system from Neusoft Medical Systems for an undisclosed amount. This acquisition is in line with Positron’s strategic objective to enhance its diagnostic capabilities, and the company is eager to validate the "Affinity PET-CT" system in collaboration with its partner in the United States. Neusoft Medical Systems is a China-based manufacturer of advanced medical imaging equipment.

Major companies operating in the positron emission tomography (pet) scanners market report are Clarity Pharmaceuticals Ltd., Hitachi Ltd., Eli Lilly and Company, Canon Medical Systems USA Inc., Toshiba Corporation, Siemens Healthineers, Fujifilm Holdings Corporation, Koninklijke Phillips N.V., GE HealthCare, Perkin Elmer Inc., CMR Naviscan Corporation, Shimadzu Corporation, Neusoft Medical Systems Co. Ltd., Blue Earth Diagnostics Limited, Mediso Medical Imaging Systems, Cubresa Inc., Oncovision, Radiology Oncology Systems Inc., FMI Medical Systems Inc., Edger Systems LLC, Mediso Ltd., MR Solutions Group Ltd., Modus Medical Devices Inc., MinFound Medical Systems Co. Ltd, PETsys Electronics SA, Yangzhou Kindsway Biotech Co. Ltd., Positron Corporation, RefleXion Medical.

North America was the largest region in the positron emission tomography (PET) scanners market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (pet) scanners market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the positron emission tomography (pet) scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) scanners market consists of revenues earned by entities by providing services such as 3D imaging, detect cellular changes, diagnostic examination and nuclear medicine imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The positron emission tomography (PET) scanner market also includes sales of positron emission tomography tracers, portable PET scanners, and time-of-flight scanners. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

A Positron Emission Tomography (PET) scanner is a medical imaging device designed to generate detailed three-dimensional images of the internal structures of the human body. It utilizes a radioactive substance to assess and detect various chronic diseases by analyzing the functions of multiple organs. PET scanners are primarily employed for cancer detection and to evaluate the effectiveness of cancer treatment.

The main modalities of Positron Emission Tomography (PET) scanners include PET-CT (Positron Emission Tomography-Computed Tomography) and PET-MRI (Positron Emission Tomography-Magnetic Resonance Imaging). PET-CT refers to a scanner that combines functional data from PET scans with images of the body obtained through the detection of radiation from CT scans. Various types of detectors, such as gadolinium oxyorthosilicate, lutetium fine silicate, bismuth germanium oxide, and lutetium oxyorthosilicate, are utilized for applications in cardiology, neurology, oncology, orthopedics, urology, gastroenterology, and others. The end-users of these devices include hospitals, diagnostic centers, and other medical facilities.

The positron emission tomography (PET) scanners market research report is one of a series of new reports that provides positron emission tomography (PET) scanners market statistics, including positron emission tomography (PET) scanners industry global market size, regional shares, competitors with a positron emission tomography (PET) scanners market share, detailed positron emission tomography (PET) scanners market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) scanners industry. This positron emission tomography (PET) scanners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.